A leader in oncology
Oncology Services (OS) is a leading,
internationally operating CRO with
unmatched expertise and extensive
experience in oncology drug development
and study management.
With operations in Europe and India,
OS provides end-to-end solutions for
drug development, including services of
Phase I to IV, regulatory affairs, consulting
for drug development, medical writing,
data management and statistics, quality
assurance and pharmacovigilance.
With oncology emerging as a
therapeutic field that demands exclusive
focus, intensive efforts and expertise for
successful drug development, Oncology
Services (OS) offers efficient clinical
study execution by bringing to bear all
of these essentials.
With a history of more than 150 clinical
trials, Oncology Services has
comprehensive expertise in all major
oncology indications, and experience in
managing all the phases of clinical trials
with more than 6,500 patients.
A vast experience in the field has
enabled OS to evolve a thorough
knowledge of patient population and
disease profile in oncology, significantly
enhancing the recruitment process.
Its well-developed network of clinical
investigators ensures swift completion of
study enrolment a key issue in achieving
successful study management.
With extensive devotion to oncology
drug trials over the years, Oncology
Services performance in oncology clinical
trials has made it a trusted and preferred
partner for some of the worlds leading
oncology research companies.
Over the years, OS has been able to win
the confidence of its clients thanks to its
work ethic, which places special emphasis
on client-CRO synergy, which in turn
ensures the service provider becomes
an extension of the clients drug
development team.
Another key aspect that results
in successful study management
is its proactive risk analysis and
contingency planning.
With these distinctive features,
Oncology Services has marked a victory
in terms of timely and efficacious
completion of projects, which is the
primary stipulation in anti-cancer
drug development.
|